搜索筛选:
搜索耗时1.5128秒,为你在为你在102,285,761篇论文里面共找到 38 篇相符的论文内容
类      型:
[会议论文] 作者:Ji Jiang, 来源:第十三次中国生物物理学术大会 年份:2013
[会议论文] 作者:Zhang Ji,Jiang Tingbo, 来源:第十二届中国介入心脏病学大会(CIT2014) 年份:2014
[会议论文] 作者:Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Xin ZHENG,Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Warren T.K.Lee,Ji Jiang,X.J.Lai,Pei Hu,H.Y.Wang, 来源:International Conference on Osteoporosis and Bone Research 2 年份:2008
[会议论文] 作者:Xin ZHENG,Qian ZHAO,Ji JIANG,Pei HU, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Xin Zheng,Xia Chen,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Xuemei Liu,Hongyun Wang,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Yang Liu,Dongyang Liu,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Diabetes mellitus is one of the most common chronic disease in the world, CPRC 1 is a novel dipeptidylpeptidase-Ⅳ(DPP-4) inhibitor which was proposed to control hyperglycemia in patients with type 2 d...
[会议论文] 作者:Xuemei Liu,Hongyun Wang,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
CPRCX is a novel investigated proton pump inhibitor, which shows dramatic success in the management of acid-related disorders.Now this drug is being developed in Phase Ⅱ study in China.In this paper f...
[会议论文] 作者:Xin Zheng,Xia Chen,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
Background: Growth hormone deficiency (GHD) in paediatric and adult patients so currently necessitates long-term treatment and persistence with a daily s.c injection regimen.Taking the low compliance...
[会议论文] 作者:Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang, 来源:第五届定量药理学与新药评价国际会议 年份:2015
Backgrounds: Roflumilast is an oral inhibitor of phosphodiesterase 4(PDE4), which is mainly metabolized by CYP3A4 and CYP1A2.The main metabolite of it is roflumilast N-oxide, which contributes to the...
[会议论文] 作者:Hongyun WANG,Ji JIANG,Pei HU,Yongming YU,Ronald G.TOMPKINS, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Xin Zheng,Kairui Feng,Pei Hu,Ji Jiang,Jun Shi, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium 年份:2013
[会议论文] 作者:Xiao Wang,Xiang Yang Hou,Ji Jiang Wang,Feng Fu, 来源:2016年中西部地区无机化学化工学术研讨会 年份:2016
  A three-dimensional metal-organic framework (MOF),namely [Cd2(BPDB)2(H2O)]n (1) (2,6-di-p-carboxyphenyl 4,4-bipyridine1=H2bpydb) has been solvothermal synth...
[会议论文] 作者:Hongyun WANG,Ji JIANG,Pei HU,Yongming YU,Ronald G.TOMPKINS, 来源:2009第十三届北京分析测试学术报告会 年份:2009
[会议论文] 作者:Xiao Wang,Xiang Yang Hou,Ji Jiang Wang,Feng Fu, 来源:2016年中西部地区无机化学化工学术研讨会 年份:2016
  A three-dimensional metal-organic framework (MOF),namely [Cd2(BPDB)2(H2O)]n (1) (2,6-di-p-carboxyphenyl 4,4'-bipyridine1=H2bpydb) has been solvothermal synt...
[会议论文] 作者:Hongyun Wang,Xia Chen,Jun Shi,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Aim:Todevelop and validate a general physiologicallybased pharmacokinetic (PBPK) model for hepatic pathway in Chinese adults at various ages, and to evaluate it with midazolam (substrate of CYP3A4) as...
相关搜索: